Faculty

Henderson, David, MD

Professor and Chair
Department of Psychiatry
Boston University School of Medicine

Psychiatrist-in-Chief
Division of Psychiatry
Boston Medical Center

Biography

David C. Henderson, MD, currently serves as Psychiatrist-in-Chief, Division of Psychiatry, at Boston Medical Center and Professor and Chair, Department of Psychiatry, at Boston University School of Medicine. Dr. Henderson previously served as Director of The Chester M. Pierce, MD Division of Global Psychiatry at Massachusetts General Hospital (MGH), Director of the MGH Schizophrenia Clinical and Research Program, and Medical Director of the Harvard Program in Refugee Trauma. Dr. Henderson serves as Co-Director of the NIMH T32 MGH-BUSM Global Mental Health Clinical Research Fellowship. Dr. Henderson has worked internationally for the past 21 years in resource-limited settings, and areas impacted by mass violence, disasters and complex emergencies.

Dr. Henderson has conducted research and training programs in Bosnia, Cambodia, East Timor, Ethiopia, Haiti, Liberia, New Orleans, New York City, Rwanda and Peru, South Africa, and Somaliland among other places. His work has consisted of field studies, needs assessments, mental health policy development and strategic planning, quantitative and qualitative surveys, mental health capacity building programs for specialized and primary health professionals, and skill-transfer program evaluation. Dr. Henderson has also directed a schizophrenia research training fellowship, and mentored trainees and junior faculty who have progressed to K awards and secured other independent funding.

In the United States, Dr. Henderson has conducted more than 30 randomized clinical trials in severely mentally ill populations. As the Director of the Schizophrenia Clinical and Research Program, he has conducted research in the area of the impact of antipsychotic agents on metabolic anomalies, glucose metabolism, diabetes and other metabolic disturbances in schizophrenia for the past 20 years. Dr. Henderson has conducted a series of studies examining the mechanisms, incidence of occurrence and interventions of weight, glucose and lipid metabolism associated with atypical antipsychotic drugs. These studies include several pharmacological interventions in randomized control trials.

Disclosure

Privacy Statement

This website uses Echo360 technologies. Echo360 partners with the world’s leading educational institutions and industry associations to enhance the teaching and learning experience for students and professionals like you. Our goal is to enable a more engaging and successful learning experience by providing you with live and on-demand access to study tools, videos, and collaboration capabilities in an online classroom to help you achieve your educational goals. We believe you should always know what data we collect from you and how we use it. As part of our ongoing commitment to transparency, and to support new European data protection laws, we're updating our Privacy Policy to inform you about the information that you share with us.

The revised policy will take effect on May 25, 2018. By using our services on or after that date, you'll be agreeing to these updates. We encourage you to read this document in full.

Echo360, Inc. 11955 Freedom Drive, Suite 700, Reston, VA 20190 USA